Alumis Inc. - Common Stock (NQ: ALMS )

12.47 +0.17 (+1.38%)

Streaming Delayed Price Updated: 10:19 AM EDT, Aug 1, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	32,114
Open	12.50
Bid (Size)	12.36 (1)
Ask (Size)	12.54 (1)
Prev. Close	12.30
Today's Range	12.35 - 12.78
52wk Range	10.45 - 13.53
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis

July 29, 2024

From Alumis Inc.

Via GlobeNewswire

Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation

July 24, 2024

Guggenheim Partners initiated coverage on Alumis, highlighting its lead asset ESK-001, a TYK2 inhibitor for plaque psoriasis and systemic lupus erythematosus. With upcoming Phase 3 trials and no JAK...

Via Benzinga

Performance

YTD	-6.24%	-6.24%
1 Month	-0.56%	-0.56%
3 Month	-6.24%	-6.24%
6 Month	-6.24%	-6.24%
1 Year	-6.24%	-6.24%

More News

Ardent Health Slips After Downsized IPO

July 21, 2024

Via Talk Markets

Immune Disease-Focused Alumis Raises $250M In Downsized Initial Public Offering

June 28, 2024

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.